Furthermore, the hypoxic environment in the lung of severe COVID-19 patients may activate HIF-1α, which mediates aerobic glycolysis, and thereby promotes the degradation of FOXP3 proteins (50). This evidence concerns the gene FOXP3 and COVID-19.